Sigilon Therapeutics Inc. (SGTX)
NASDAQ: SGTX
· Real-Time Price · USD
22.47
-0.59 (-2.56%)
At close: Aug 10, 2023, 10:00 PM
Sigilon Therapeutics Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | 5.9M | 4.86M | 2.64M | 4.25M | 2.88M | 3.17M | 1.99M | 1.95M | 2.7M | 2.96M |
Cost of Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit | 5.9M | 4.86M | 2.64M | 4.25M | 2.88M | 3.17M | 1.99M | 1.95M | 2.7M | 2.96M |
Operating Income | -7.43M | -7.25M | -7.73M | -8.42M | -14.04M | -13.48M | -17.29M | -19.74M | -20.04M | -18.57M |
Interest Income | 433K | 476K | 404K | 300K | 178K | 64K | 46K | 56K | 71K | 86K |
Pretax Income | -7.51M | -7.38M | -6.68M | -8.67M | -14.35M | -13.86M | -17.75M | -20.16M | -20.44M | -18.97M |
Net Income | -7.51M | -7.51M | -5.64M | -8.92M | -14.66M | -13.86M | -17.75M | -20.16M | -20.44M | -18.97M |
Selling & General & Admin | 5.88M | 4.32M | 4.52M | 4.39M | 5.04M | 5.02M | 4.59M | 5.04M | 4.99M | 5.54M |
Research & Development | 7.45M | 7.78M | 5.86M | 8.28M | 11.88M | 11.62M | 14.69M | 16.64M | 17.75M | 15.98M |
Other Expenses | 81K | 4K | n/a | 58K | 55K | 45K | 8K | 26K | 25K | -4K |
Operating Expenses | 13.34M | 12.11M | 10.37M | 12.68M | 16.92M | 16.64M | 19.28M | 21.69M | 22.74M | 21.52M |
Interest Expense | 310K | 611K | 650K | 606K | 543K | 491K | 507K | 499K | 494K | 488K |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 13.34M | 12.11M | 10.37M | 12.68M | 16.92M | 16.64M | 19.28M | 21.69M | 22.74M | 21.52M |
Income Tax Expense | n/a | 131K | -1.04M | 248K | 310K | n/a | n/a | 525K | 519K | 484K |
Shares Outstanding (Basic) | 32.47M | 32.47M | 32.46M | 32.4M | 32.4M | 2.49M | 2.46M | 2.47M | 2.43M | 2.42M |
Shares Outstanding (Diluted) | 32.47M | 32.47M | 32.46M | 32.4M | 32.4M | 2.49M | 2.46M | 2.47M | 2.43M | 2.42M |
EPS (Basic) | -0.23 | -0.23 | -0.17 | -0.28 | -0.45 | -5.57 | -7.22 | -8.17 | -8.42 | -7.83 |
EPS (Diluted) | -0.23 | -0.23 | -0.17 | -0.28 | -0.45 | -5.57 | -7.22 | -8.17 | -8.42 | -7.83 |
EBITDA | -6.61M | -6.45M | -6.04M | -7.75M | -13.49M | -13.05M | -17.24M | -19.35M | -19.68M | -18.24M |
EBIT | -7.2M | -6.77M | -6.04M | -8.06M | -13.8M | -13.37M | -17.24M | -19.21M | -19.52M | -18.08M |
Depreciation & Amortization | 310K | 795K | 1.7M | 674K | 550K | 316K | 302K | 306K | 263K | 247K |